Crossmark

Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly

Crossref DOI link: https://doi.org/10.1007/s11102-018-0873-7

Published Online: 2018-02-03

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chiloiro, Sabrina

Mazziotti, Gherardo

Giampietro, Antonella

Bianchi, Antonio

Frara, Stefano

Mormando, Marilda

Pontecorvi, Alfredo

Giustina, Andrea

De Marinis, Laura
License Information

Text and Data Mining valid from 2018-02-03
More Information

Article History

First Online: 3 February 2018

Change Date: 23 February 2018

Change Type: Correction

Change Details: The original version of the article contained an error in the results section of the Abstract. The vertebral fractures (VFs) odds ratio is incorrectly published as 61.0 and the correct value is 6.10.

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.